Skip to main content
Novonesis AS logo

Novonesis AS — Investor Relations & Filings

Ticker · NSIS ISIN · DK0060336014 LEI · 529900T6WNZXD2R3JW38 CO Manufacturing
Open in API
Filings indexed 2,308 across all filing types
Latest filing 2026-02-25 Annual Report (ESEF)
Country DK Denmark
Listing CO NSIS

About Novonesis AS

https://www.novozymes.com/en

Novonesis is a global biosolutions company formed through the combination of Novozymes and Chr. Hansen. The company develops and produces a broad portfolio of biological solutions, including industrial enzymes, functional proteins, and microorganisms such as cultures, probiotics, and yeast. Its products are utilized in over 30 industries to improve efficiency, sustainability, and product quality. Key markets include food and beverage, where solutions enhance nutrition and reduce waste; human and animal health; agriculture, promoting higher crop yields and animal welfare; and household care, for more effective cleaning. Novonesis applies biotechnological principles to address global challenges in production and consumption, aiming to create more sustainable systems and products.

Recent filings

Filing Released Lang Actions
Novonesis' Annual Report 2025
Annual Report (ESEF) Classification · 100% confidence FY 2025
2026-02-25 English
Novonesis' Annual Report 2025
Report Publication Announcement Classification · 100% confidence The document is a short summary (under 5,000 characters) providing key financial highlights for the 2025 fiscal year. It explicitly states 'Please read the full announcement and annual report attached' and provides links to the actual report files. According to the 'Menu vs Meal' rule, this is a Report Publication Announcement (RPA) rather than the Annual Report (10-K) itself.
2026-02-25 English
Director's Dealing 2025
Director's Dealing Classification · 100% confidence The document is a short announcement (555 characters) regarding 'Trading by management and close relations of management'. It explicitly directs the reader to a PDF attachment for the full details. According to the 'Menu vs Meal' rule, since this is a short announcement pointing to an external document rather than the report itself, it is classified as a Report Publication Announcement (RPA).
2025-11-21 English
Director's Dealing 2025
Director's Dealing Classification · 100% confidence The document is a formal notification of a share purchase by a person discharging managerial responsibilities (the Vice Chair of the Board). It explicitly cites Regulation (EU) No 596/2014 (Market Abuse Regulation) regarding transactions by management and close relations. This aligns perfectly with the definition of 'Director's Dealing' (Code: DIRS), which covers reports of personal share transactions by company directors and executives.
2025-11-21 English
Director's Dealing 2025
Director's Dealing Classification · 100% confidence The document is a formal notification of a share purchase by an Executive Vice President (Morten Enggaard Rasmussen) of Novonesis. It explicitly cites Article 19 of the Market Abuse Regulation (EU) No 596/2014, which governs the disclosure of transactions by persons discharging managerial responsibilities (PDMRs). This aligns perfectly with the definition of 'Director's Dealing' (DIRS).
2025-11-07 English
Director's Dealing 2025
Director's Dealing Classification · 100% confidence The document is a short announcement (555 characters) titled 'Trading by management and close relations of management' which directs the reader to an external PDF attachment for the full details. This fits the 'Menu vs Meal' rule where the document is an announcement of a report/filing rather than the report itself. Since it specifically concerns director/management trading, it falls under the category of Director's Dealing (DIRS).
2025-11-07 English

Browse filings by year

20 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.